An ROC curve analysis was conducted to evaluate the diagnostic performance of postoperative peak levels of hs-TnI, CK-MB, and Mb in predicting clinical outcomes in pediatric patients with CHD. This evidence concerns the gene MAP3K14 and coronary artery disorder.